Guidant CrossSail
This article was originally published in The Gray Sheet
Executive Summary
Rapid-exchange coronary dilatation catheter and OpenSail over-the-wire counterpart gain FDA market go-ahead for use in native coronary vessels and saphenous vein grafts. The angioplasty devices offer "the smallest profiles of any coronary dilatation catheter currently available," Guidant claims, and "incorporate significant technological advancements." Launched earlier this year in CE mark countries, CrossSail's U.S. debut is set for early July, while the OpenSail will be introduced "upon completion of the CrossSail launch," Guidant says. The devices feature a SofTech tip with a "soft, tapered-tip shape," LoFold balloon folding technology, Xcelon S nylon-blend balloon material and Hydrocoat hydrophilic coating